医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

外科

Propanc Biopharma Undertaking PRP Manufacturing ＆ Development for Human Use

バイオテクノロジーヘルスケアヘルス一般外科病院腫瘍学臨床試験製薬遺伝学　 TimeLine: Development for Human Use Propanc Biopharma Undertaking PRP Manufacturing

2022年05月18日

Propanc Biopharma Offers a Novel Way to Stop Cancer

バイオテクノロジーヘルスケアヘルス一般外科病院腫瘍学臨床試験製薬遺伝学　 TimeLine: Propanc Biopharma Offers a Novel Way to Stop Cancer

2022年05月11日

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

ヘルスケア医療機器外科心臓学病院臨床試験　 TimeLine: First Patients Outside of Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

2022年05月03日

Propanc Biopharma Purchases Pharma Grade Raw Materials for PRP Manufacture in Preparation for Phase I First-In-Human Study

バイオテクノロジーヘルスケアヘルス一般外科病院腫瘍学臨床試験製薬遺伝学　 TimeLine: I First-In-Human Study Propanc Biopharma Purchases Pharma Grade Raw Materials for PRP Manufacture in Preparation for Phase

2022年05月02日

Lemonex Announces IND Approval for Phase 1 Clinical Trial of LEM-S401, siRNA Gene Therapeutics With Nano-Drug Delivery Platform DegradaBALL®

Lemonex Announces IND Approval for Phase 1 Clinical Trial of LEM-S401, siRNA Gene Therapeutics With Nano-Drug Delivery Platform DegradaBALL®

バイオテクノロジーヘルスケア外科臨床試験製薬遺伝学　 TimeLine: Clinical Trial of LEM-S401 DegradaBALL Gene Therapeutics With Nano-Drug Delivery Platform IND Approval for Phase Lemonex Announces

2022年04月26日

Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

バイオテクノロジーヘルスケア外科感染症臨床試験製薬　 TimeLine: maribavir New Exploratory Analysis Showing Patients Treated With LIVTENCITY Takeda Presents

2022年04月22日

Propanc Biopharma’s Management Explains Why They Believe Cancer Patients Are Likely to Respond to PRP Treatment

バイオテクノロジーヘルスケアヘルス一般外科病院腫瘍学臨床試験製薬遺伝学　 TimeLine: Propanc Biopharma’s Management Explains Why They Believe Cancer Patients Are Likely to Respond to PRP Treatment

2022年04月13日

Propanc Biopharma’s CEO Expresses Concern Over Disruption to Cancer Care During Global Pandemic

バイオテクノロジーヘルスケアヘルス一般外科感染症腫瘍学臨床試験製薬遺伝学　 TimeLine: Propanc Biopharma’s CEO Expresses Concern Over Disruption to Cancer Care During Global Pandemic

2022年04月06日

First Patient in Japan Treated with Impella 5.5 with SmartAssist

First Patient in Japan Treated with Impella 5.5 with SmartAssist

バイオテクノロジーヘルスケアヘルス一般医療機器外科心臓学病院　 TimeLine: First Patient in Japan Treated with Impella 5.5 with SmartAssist

2022年04月06日